Welcure Drugs [WELCURE] vs Gujarat Themis [GUJTHEM] Detailed Stock Comparison

Welcure Drugs

BSE
Loading...

Gujarat Themis

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Welcure Drugs wins in 7 metrics, Gujarat Themis wins in 12 metrics, with 0 ties. Gujarat Themis appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricWelcure DrugsGujarat ThemisBetter
P/E Ratio (TTM)2.24103.15Welcure Drugs
Price-to-Book Ratio0.4518.55Welcure Drugs
Debt-to-Equity Ratio120.1812.27Gujarat Themis
PEG Ratio0.00-3.26Gujarat Themis
EV/EBITDA5.5771.94Welcure Drugs
Profit Margin (TTM)7.96%30.17%Gujarat Themis
Operating Margin (TTM)10.38%33.14%Gujarat Themis
EBITDA Margin (TTM)10.38%33.14%Gujarat Themis
Return on Equity2.12%19.64%Gujarat Themis
Return on Assets (TTM)0.81%16.19%Gujarat Themis
Free Cash Flow (TTM)$-2.22B$-251.22MGujarat Themis
Dividend YieldN/A0.17%N/A
1-Year Return-13.65%89.42%Gujarat Themis
Price-to-Sales Ratio (TTM)0.2131.17Welcure Drugs
Enterprise Value$1.91B$46.35BGujarat Themis
EV/Revenue Ratio0.5931.35Welcure Drugs
Gross Profit Margin (TTM)10.40%77.71%Gujarat Themis
Revenue per Share (TTM)$38$14Welcure Drugs
Earnings per Share (Diluted)$2.69$4.10Gujarat Themis
Beta (Stock Volatility)-2.07-0.37Welcure Drugs
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Welcure Drugs vs Gujarat Themis Stock Performance Analysis

Loading Price Chart...

Welcure Drugs
Gujarat Themis
Welcure Drugs Stock Overview | Gujarat Themis Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Welcure Drugs4.97%20.73%-33.73%-43.59%-19.42%-40.13%
Gujarat Themis-1.46%5.04%8.07%20.17%66.93%70.32%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Welcure Drugs-13.65%-18.73%225.49%196.43%109.46%-49.31%
Gujarat Themis89.42%89.42%89.42%89.42%89.42%89.42%

News Based Sentiment: Welcure Drugs vs Gujarat Themis

Welcure Drugs

News based Sentiment: MIXED

October was a pivotal month for Welcure Drugs, marked by a potential acquisition offer and significant financial growth, but also continued stock volatility and regulatory scrutiny. The mixed signals create a complex investment picture, making it a significant month for the company's trajectory.

View Welcure Drugs News Sentiment Analysis

Gujarat Themis

News based Sentiment: MIXED

October 2025 was a mixed month for Gujarat Themis Biosyn Ltd., with declining financial results countered by positive stock movement and investor sentiment. While the revenue and profit decreases are concerning, the market's reaction and analyst targets suggest potential for recovery, making it a cautiously optimistic outlook.

View Gujarat Themis News Sentiment Analysis

Performance & Financial Health Analysis: Welcure Drugs vs Gujarat Themis

MetricWELCUREGUJTHEM
Market Information
Market Cap i₹712.18M₹46.19B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i8,204,994353,996
90 Day Avg. Volume i6,251,926202,276
Last Close₹6.97₹408.60
52 Week Range₹5.26 - ₹15.89₹208.00 - ₹434.25
% from 52W High-56.14%-5.91%
All-Time High₹25.00 (Sep 19, 2005)₹434.25 (Oct 06, 2025)
% from All-Time High-72.12%-5.91%
Growth Metrics
Quarterly Revenue Growth-34.93%-0.08%
Quarterly Earnings GrowthN/A-0.32%
Financial Health
Profit Margin (TTM) i0.08%0.30%
Operating Margin (TTM) i0.10%0.33%
Return on Equity (TTM) i0.02%0.20%
Debt to Equity (MRQ) i120.1812.27
Cash & Liquidity
Book Value per Share (MRQ)₹13.32₹22.80
Cash per Share (MRQ)₹0.01₹1.15
Operating Cash Flow (TTM) i₹-2,249,340,000₹970.68M
Levered Free Cash Flow (TTM) i₹21.70M₹487.72M
Dividends
Last 12-Month Dividend Yield iN/A0.17%
Last 12-Month Dividend iN/A₹0.67

Valuation & Enterprise Metrics Analysis: Welcure Drugs vs Gujarat Themis

MetricWELCUREGUJTHEM
Price Ratios
P/E Ratio (TTM) i2.24103.15
Forward P/E iN/AN/A
PEG Ratio i0.00-3.26
Price to Sales (TTM) i0.2131.17
Price to Book (MRQ) i0.4518.55
Market Capitalization
Market Capitalization i₹712.18M₹46.19B
Enterprise Value i₹1.91B₹46.35B
Enterprise Value Metrics
Enterprise to Revenue i0.5931.35
Enterprise to EBITDA i5.5771.94
Risk & Other Metrics
Beta i-2.07-0.37
Book Value per Share (MRQ) i₹13.32₹22.80

Financial Statements Comparison: Welcure Drugs vs Gujarat Themis

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)WELCUREGUJTHEM
Revenue/Sales i₹3.00B₹358.73M
Cost of Goods Sold i₹2.69B₹79.97M
Gross Profit i₹311.96M₹278.76M
Research & Development iN/AN/A
Operating Income (EBIT) i₹311.36M₹118.87M
EBITDA i₹311.41M₹141.96M
Pre-Tax Income i₹311.36M₹121.20M
Income Tax i₹78.37M₹30.58M
Net Income (Profit) i₹232.99M₹90.62M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)WELCUREGUJTHEM
Cash & Equivalents i₹1.28M₹116.94M
Total Current Assets i₹1.82B₹519.73M
Total Current Liabilities i₹412.69M₹205.60M
Long-Term Debt i₹1.23B₹296.36M
Total Shareholders Equity i₹1.03B₹2.48B
Retained Earnings i₹-100.79M₹2.37B
Property, Plant & Equipment iN/A₹411.30M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)WELCUREGUJTHEM
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricWELCUREGUJTHEM
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i8,204,994353,996
Average Daily Volume (90 Day) i6,251,926202,276
Shares Outstanding i112.51M108.97M
Float Shares i14.84M30.70M
% Held by Insiders i0.85%0.71%
% Held by Institutions i0.00%0.01%

Dividend Analysis & Yield Comparison: Welcure Drugs vs Gujarat Themis

MetricWELCUREGUJTHEM
Last 12-Month Dividend iN/A₹0.67
Last 12-Month Dividend Yield iN/A0.17%
3-Year Avg Annual Dividend iN/A₹0.22
3-Year Avg Dividend Yield iN/A0.17%
3-Year Total Dividends iN/A₹0.67
Ex-Dividend DateN/ASep 04, 2025